Anti-mycotoxin additive receives first positive opinion on effectiveness

Biomin received a positive opinion on mycotoxin biotransformation by the European Food Safety Authority. The authority concluded that Biomin BBSH 797 (part of the Mycofix product line) is safe for animals, humans and the environment.

Biomin received a positive opinion on mycotoxin biotransformation by the European Food Safety Authority. The authority concluded that Biomin BBSH 797 (part of the Mycofix product line) is safe for animals, humans and the environment. The additive also demonstrated effectiveness on the target species.

Following a request from the European Commission, the Panel on Additives and Products or Substances Used in Animal Feed acknowledged the product's ability to reduce the epoxide group of trichothecenes to produce less toxic and harmless metabolites. The panel concluded that the evidence studies confirmed that this usefulness can transferred to animals when the additive is incorporated into trichothecene-contaminated diets.

Trichothecenes comprise the largest group of mycotoxins. They are one of the major mycotoxins groups affecting not just Europe but worldwide. According to the latest Biomin mycotoxin survey report 2012 which analyzed 4,023 samples worldwide, deoxynivalenol, another type of mycotoxin, was found in 64 percent of all samples.

"In 2010, we were the first feed additive company to submit a dossier for an aflatoxin binder and the first to have a positive opinion by the European Food Safety Authority on the approval of a feed additive with mycotoxin-counteracting properties. The dossier for the trichothecene-biotransforming product Biomin BBSH 797 was submitted only a few months after the European Food Safety Authority officially published their guidance document in 2012," said Dian Schatzmayr, Director of Competence Center Mycotoxins within the Biomin Research Center.

"The fact that the evaluation process was completed in record time attests once again to the significant level of research and development investment and Biomin's leadership in mycotoxin risk-management," Schatzmayr said. 

Page 1 of 51
Next Page